Bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to ...

Symptoms to look out for and when to see a doctor - There are roughly 10,000 people a year diagnosed with bladder cancer in ...

The trial showed a 'clinically meaningful' and 'statistically significant' improvement when treated with therapy plus BCG, ...

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Common symptoms like blood in urine or frequent urination should prompt a visit to a urologist. Early evaluation is crucial for effective bladder cancer management. Consult a urologist promptly for ...

Adding a PD-1 antibody to BCG led to improved event-free survival in patients with non–muscle invasive bladder cancer.

Bladder cancer patients treated with a breakthrough drug are a third less likely to see their disease return and have higher ...

Reported positive six-month data from ADVANCED-2 trial of TARA-002 in patients with NMIBC Completed approximately $100 ...

Sens. Chuck Schumer and Kirsten Gillibrand, and U.S. Rep. Tim Kennedy, met with the DEC to learn more about pollution from the Goodyear plant in Niagara Falls.

While several molecular markers that are used to evaluate the development and prognosis of bladder cancer have been studied, the limited value of these established markers has created the need for ...